Recent Updates
Recently added Catalysts
ECOR Positive Sentiment

electroCore to Participate in the Lytham Partners Fall 2023 Virtual Investor Conference

Key Takeaway: electroCore, Inc. will participate in the Lytham Partners Fall 2023 Investor Conference on October 17, 2023. CEO Dan Goldberger will be available for virtual one-on-one meetings with investors. This event aims to strengthen investor relations and promote the company's bioelectronic medicine offerings. The participation underscores electroCore's commitment to improving health through its non-invasive vagus nerve stimulation technology.
Price reaction · baseline $6.32 (2023-10-04 close) · hit after-hours · 1 other ECOR headline(s) in the window, move may be shared
day 0 close · peak
-3.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • CEO Dan Goldberger's participation could enhance investor interest.
  • The virtual conference provides a platform for direct interaction with management.
  • Focus on non-invasive technologies positions electroCore favorably in the wellness market.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~7 mo
High dilution risk
Lead asset
GammaCore
Phase 2 · Chronic Cluster Headache

Full Press Release Details

ROCKAWAY, N.J., Oct. 05, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger, will be participating in the Lytham Partners Fall 2023 Investor Conference taking place virtually on Tuesday, October 17, 2023.
Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners at 1x1@lythampartners.com or register at https://www.lythampartners.com/fall2023invreg/.
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.
For more information, visit www.electrocore.com.

Frequently Asked Questions

When is electroCore's event participation?

electroCore's CEO will participate in the Lytham Partners Fall 2023 Investor Conference on October 17.

How can I arrange a meeting with electroCore management?

To arrange a meeting, contact Lytham Partners at 1x1@lythampartners.com.

What is electroCore focused on?

electroCore specializes in bioelectronic medicine, notably non-invasive vagus nerve stimulation.

What technology does electroCore use?

electroCore utilizes a non-invasive vagus nerve stimulation platform for health management.

Where can I find more information about electroCore?

Visit electroCore's website at www.electrocore.com for more details.

Last updated: Oct 5, 2023